Zepp Health [ZEPP] vs Apple [AAPL] Detailed Stock Comparison
Zepp Health
NYSE
Loading...
Apple
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Zepp Health wins in 8 metrics, Apple wins in 10 metrics, with 0 ties. Apple appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Zepp Health | Apple | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.31 | 32.36 | Zepp Health |
| Price-to-Book Ratio | 1.57 | 48.13 | Zepp Health |
| Debt-to-Equity Ratio | 47.49 | 154.49 | Zepp Health |
| PEG Ratio | -2,239.00 | 25.66 | Zepp Health |
| EV/EBITDA | -105.68 | 22.66 | Zepp Health |
| Profit Margin (TTM) | -38.81% | 24.30% | Apple |
| Operating Margin (TTM) | -10.27% | 29.99% | Apple |
| EBITDA Margin (TTM) | N/A | 29.99% | N/A |
| Return on Equity | -28.32% | 149.81% | Apple |
| Return on Assets (TTM) | -5.10% | 24.55% | Apple |
| Free Cash Flow (TTM) | $-25.88M | $108.81B | Apple |
| Dividend Yield | N/A | 0.62% | N/A |
| 1-Year Return | 849.22% | 1.82% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 1.61 | 7.74 | Zepp Health |
| Enterprise Value | $4.47B | $3,211.04B | Apple |
| EV/Revenue Ratio | 22.34 | 7.86 | Apple |
| Gross Profit Margin (TTM) | 37.27% | 46.49% | Apple |
| Revenue per Share (TTM) | $12 | $27 | Apple |
| Earnings per Share (Diluted) | $-4.80 | $6.59 | Apple |
| Beta (Stock Volatility) | 1.12 | 1.17 | Zepp Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Zepp Health vs Apple Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Zepp Health | -4.07% | 80.53% | 598.28% | 860.47% | 740.83% | 746.69% |
| Apple | 4.24% | 6.00% | 4.80% | 12.12% | -3.34% | -9.77% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Zepp Health | 849.22% | 197.79% | -58.39% | -46.62% | -46.62% | -46.62% |
| Apple | 1.82% | 27.93% | 91.60% | 659.47% | 2,373.82% | 13,243.64% |
Performance & Financial Health Analysis: Zepp Health vs Apple
| Metric | ZEPP | AAPL |
|---|---|---|
| Market Information | ||
| Market Cap | $321.70M | $3.16T |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 333,011 | 63,196,890 |
| 90 Day Avg. Volume | 1,044,594 | 55,518,623 |
| Last Close | $24.30 | $229.37 |
| 52 Week Range | $2.08 - $27.86 | $169.21 - $260.10 |
| % from 52W High | -12.78% | -11.81% |
| All-Time High | $81.00 (Feb 15, 2021) | $260.10 (Dec 23, 2024) |
| % from All-Time High | -70.00% | -11.81% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | 0.10% |
| Quarterly Earnings Growth | 5.89% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | -0.39% | 0.24% |
| Operating Margin (TTM) | -0.10% | 0.30% |
| Return on Equity (TTM) | -0.28% | 1.50% |
| Debt to Equity (MRQ) | 47.49 | 154.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.22 | $4.43 |
| Cash per Share (MRQ) | $0.22 | $3.73 |
| Operating Cash Flow (TTM) | $-25,970,000 | $108.56B |
| Levered Free Cash Flow (TTM) | $-134,703,985 | $94.87B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.62% |
| Last 12-Month Dividend | $0.00 | $1.27 |
Valuation & Enterprise Metrics Analysis: Zepp Health vs Apple
| Metric | ZEPP | AAPL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.31 | 32.36 |
| Forward P/E | -2,239.00 | 25.66 |
| PEG Ratio | -2,239.00 | 25.66 |
| Price to Sales (TTM) | 1.61 | 7.74 |
| Price to Book (MRQ) | 1.57 | 48.13 |
| Market Capitalization | ||
| Market Capitalization | $321.70M | $3.16T |
| Enterprise Value | $4.47B | $3.21T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 22.34 | 7.86 |
| Enterprise to EBITDA | -105.68 | 22.66 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 1.17 |
| Book Value per Share (MRQ) | $14.22 | $4.43 |
Financial Statements Comparison: Zepp Health vs Apple
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ZEPP | AAPL |
|---|---|---|
| Revenue/Sales | $38.54M | $95.36B |
| Cost of Goods Sold | $24.18M | $50.49B |
| Gross Profit | $14.36M | $44.87B |
| Research & Development | $12.38M | $8.55B |
| Operating Income (EBIT) | $-18.38M | $29.59B |
| EBITDA | $-17.79M | $32.25B |
| Pre-Tax Income | $-19.27M | $29.31B |
| Income Tax | $110,000 | $4.53B |
| Net Income (Profit) | $-19.74M | $24.78B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ZEPP | AAPL |
|---|---|---|
| Cash & Equivalents | $76.43M | $28.16B |
| Total Current Assets | $242.46M | $118.67B |
| Total Current Liabilities | $212.34M | $144.57B |
| Long-Term Debt | $71.16M | $78.57B |
| Total Shareholders Equity | $232.04M | $66.80B |
| Retained Earnings | $8.88M | $-15.55B |
| Property, Plant & Equipment | $9.56M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ZEPP | AAPL |
|---|---|---|
| Operating Cash Flow | $-14.63M | $23.95B |
| Capital Expenditures | $-2.92M | $-3.07B |
| Free Cash Flow | $-16.89M | $20.88B |
| Debt Repayment | N/A | $976.00M |
| Common Stock Repurchase | N/A | $-25.90B |
Short Interest & Institutional Ownership Analysis
| Metric | ZEPP | AAPL |
|---|---|---|
| Shares Short | 308,546 | 93.95M |
| Short Ratio | 0.25 | 1.74 |
| Short % of Float | 0.05% | 0.01% |
| Average Daily Volume (10 Day) | 333,011 | 63,196,890 |
| Average Daily Volume (90 Day) | 1,044,594 | 55,518,623 |
| Shares Outstanding | 231.98M | 15.12B |
| Float Shares | 108.71M | 14.81B |
| % Held by Insiders | 0.06% | 0.02% |
| % Held by Institutions | 0.26% | 0.63% |
Dividend Analysis & Yield Comparison: Zepp Health vs Apple
| Metric | ZEPP | AAPL |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $1.27 |
| Last 12-Month Dividend Yield | N/A | 0.62% |
| 3-Year Avg Annual Dividend | $0.00 | $0.98 |
| 3-Year Avg Dividend Yield | N/A | 0.13% |
| 3-Year Total Dividends | $0.00 | $2.94 |
| Ex-Dividend Date | N/A | Aug 11, 2025 |